Studies have demonstrated that depletion of HO-1 expression by specific gene knockdown approach or inhibition of HO-1 activity by competitive inhibitors, such as zinc protoporphyrin IX, increases tumor sensitivity to chemotherapeutic agent or irradiation-induced cell death and suppresses cancer metastasis [5–8]. This evidence concerns the gene HMOX1 and cancer.